Exilby

First cannabis-based chronic pain drug wins approval in Germany and Austria

German biopharmaceutical company Vertanical announced on Monday that Exilby (VER-01), a cannabis-derived oral tincture, has received marketing authorization in Germany for the treatment of chronic low back pain with a neuropathic component, making it the first cannabis-based medication explicitly approved…